申请人:Orion-yhtyma Oy
公开号:US05439928A1
公开(公告)日:1995-08-08
Novel 4(5)-imidazole derivatives of specified formula and their non-toxic salts possess selective aromatase inhibiting properties, which are valuable in the treatment of estrogen dependent diseases e.g. breast cancer.
指定公式的新颖4(5)-咪唑衍生物及其无毒盐具有选择性芳香化酶抑制特性,对治疗依赖雌激素的疾病如乳腺癌具有重要价值。